These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 24258015)
1. Synthesis, cytostatic, and antitumor properties of new rh(i) thiazole complexes. Craciunescu DG; Furlani A; Scarcia V; Doadrio A Biol Trace Elem Res; 1985 Dec; 8(4):251-61. PubMed ID: 24258015 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of new Rh (I) complexes with sulfonamide derivatives. Craciunescu G; Scarcia V; Furlani A; Iglesias EP; Ghirvu C; Papaioannou A Anticancer Res; 1989; 9(3):781-5. PubMed ID: 2764523 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological and toxicological studies on new Rh(I) organometallic complexes. Craciunescu DG; Scarcia V; Furlani A; Papaioannou A; Parrondo Iglesias E; Alonso MP In Vivo; 1991; 5(4):329-32. PubMed ID: 1810417 [TBL] [Abstract][Full Text] [Related]
4. On the synthesis, cytostatic and antitumor properties of new Pt(II) and Pt(IV) complexes with chloroanilines. Craciunescu DG; Furlani A; Scarcia V; Ghirvu C; Doadrio A Chem Biol Interact; 1985; 53(1-2):45-56. PubMed ID: 3995655 [TBL] [Abstract][Full Text] [Related]
5. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity. Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251 [TBL] [Abstract][Full Text] [Related]
6. A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV). Kizu R; Nakanishi T; Hayakawa K; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Tashiro T; Kidani Y Cancer Chemother Pharmacol; 1999; 43(2):97-105. PubMed ID: 9923814 [TBL] [Abstract][Full Text] [Related]
7. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo. Guo QL; Wu MS; Chen Z Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors. Mazerska Z; Lukowicz J; Konopa J Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249 [TBL] [Abstract][Full Text] [Related]
17. Platinum and palladium complexes containing ethylenediamine derivatives as carrier ligands and their antitumor activity. Lee K; Tashiro T; Noji M Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):702-3. PubMed ID: 8004720 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives. Trávnícek Z; Szucová L; Popa I J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and antitumor activity of novel octahedral Pt(IV) complexes. Kwon YE; Whang KJ; Park YJ; Kim KH Bioorg Med Chem; 2003 Apr; 11(8):1669-76. PubMed ID: 12659753 [TBL] [Abstract][Full Text] [Related]
20. Cytostatic and antitumour properties of a new series of Pt (II) complexes with cyclopentylamine. Craciunescu DG; Scarcia V; Furlani A; Doadrio A; Ghirvu C; Ravalico L In Vivo; 1987; 1(4):229-34. PubMed ID: 2979788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]